NanoXplore licenses Arteris FlexGen NoC IP for radiation-hardened FPGAs

Published 23/09/2025, 14:06
NanoXplore licenses Arteris FlexGen NoC IP for radiation-hardened FPGAs

CAMPBELL, Calif. - NanoXplore, a provider of radiation-hardened FPGA technology, has licensed Arteris FlexGen smart network-on-chip (NoC) IP for its aerospace designs, Arteris (NASDAQ:AIP) announced Tuesday. The announcement comes as Arteris shows strong market momentum, with InvestingPro data showing a 14.35% stock return over the past week and a market capitalization of $445 million.

The technology will be integrated into NanoXplore’s development of complex FPGA structures aimed at mission-critical computing in aerospace applications, according to a press release statement.

FlexGen is designed to automate NoC generation, enabling engineers to create optimized networks for data movement in space applications more efficiently. The technology aims to minimize wire length, power consumption and silicon area while optimizing performance.

"The introduction of FlexGen smart NoC IP into our NoC design process has significantly strengthened our leadership in highly reliable semiconductor solutions," said Alp Kilic, CTO of NanoXplore. Arteris maintains impressive operational efficiency with a gross profit margin of 90%, according to InvestingPro data, while holding more cash than debt on its balance sheet.

NanoXplore, a French fabless company, provides radiation-hardened FPGA devices for high-reliability environments, particularly in space and avionics. The company recently launched the NG-ULTRA, which it claims is the most advanced radiation-hardened SoC FPGA.

Arteris, headquartered in Campbell, California, provides system IP for semiconductor creation. The company’s network-on-chip interconnect IP and system-on-chip integration automation software are used by semiconductor and technology companies to improve performance and engineering productivity.

Financial terms of the licensing agreement were not disclosed in the announcement. Want deeper insights into Arteris’s financial health and growth potential? InvestingPro offers exclusive access to detailed financial analysis, including 8 additional ProTips and comprehensive valuation metrics in the Pro Research Report, helping investors make more informed decisions.

In other recent news, Arteris Inc. reported its second-quarter 2025 earnings, revealing a revenue of $16.5 million, which surpassed the forecast of $16.35 million. However, the company’s earnings per share (EPS) was slightly below expectations at -$0.11 compared to the predicted -$0.10. Despite the minor EPS shortfall, the revenue beat has been a positive highlight for investors. Additionally, Arteris announced its membership in the Ultra Accelerator Link Consortium, a group formed to advance AI accelerator standards. This consortium includes major technology companies such as AMD, AWS, Google, Intel, Meta, and Microsoft. These recent developments underscore Arteris’ strategic moves in the semiconductor industry. While the earnings report and consortium membership are significant, no analyst upgrades or downgrades have been reported. These updates reflect Arteris’ ongoing efforts to strengthen its market position.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.